Jared Saffie Passes M.S. Defense
Congrats to our newest graduate! Jared will stay on with the lab for his Ph.D.!
Author: Catherine M Klapperich
New Center for Future Technologies in Cancer Care at BU!
Boston University is now home to the new Center for Future Technologies in Cancer Care (FTCC). See the fabulous article about the FTCC at BU Today.
Microfluidics 2.0 2012 Speaker List Finalized
The speaker list for Microfluidics 2.0 2012 has been finalized! Please check it out and register at www-staging.bu.edu/klapperich/mf20.
Dr. Klapperich is a STEMinist!
Ok, so her picture isn’t as cool as some of the others, but Dr. Klapperich still adds her name to those supporting young women pursuing STEM careers at www.steminist.com.
Flu Chips Profiled on Nature Medicine Blog
The Klapperich Lab and others are mentioned in a Nature Medicine blog post about new influenza A molecular tests.
Microfluidic Flu Chip Paper Published in PLoS ONE
Microfluidic Chip for Molecular Amplification of Influenza A RNA in Human Respiratory Specimens A rapid, low cost, accurate point-of-care (POC) device to detect influenza virus is needed for effective treatment and control of both seasonal and pandemic strains. We developed a single-use microfluidic chip that integrates solid phase extraction (SPE) and molecular amplification via a […]
Dr. Klapperich to Speak in Kenya at “Bringing Diagnostic Prototypes to the Point of Care”
KENYA WORKSHOP: Bringing Diagnostic Prototypes to the Point of Care June 25-29, 2012 Institute of Primate Research (IPR) – Nairobi, Kenya List of Speakers
Minimally Instrumented Diagnostics Cartoon-ified!
Click here for the full pdf file!
Work with the Murthy Lab at NEU highlighted in CEN
Chemical and Engineering News recently spotlighted the work of the Murthy Lab at Northeastern isolating rare cancer cells from complicated samples. Dr. Madhumita Mahalanabis of the Klapperich Lab contributed to this work. Sorting Cells From Whole Blood “Medical Diagnostics: A microfluidic device that separates rare cells could help diagnose cancer” Link to the Analytical Chemistry paper.
Alternative to Dried Blood Spot Analysis
The U.S. President’s Emergency Plan for AIDS Relief, in conjunction with the Global Fund has initiated antiretroviral therapy (ART) for 3.7 million patients in the developing world as of 2009. However, the distribution of therapy has outpaced the ability of most countries to monitor patients for treatment failure. Two diagnostic tests are performed to assess […]